BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22407595)

  • 1. S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.
    Tomasi ML; Tomasi I; Ramani K; Pascale RM; Xu J; Giordano P; Mato JM; Lu SC
    Hepatology; 2012 Sep; 56(3):982-93. PubMed ID: 22407595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
    Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
    Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells.
    Ramani K; Robinson AE; Berlind J; Fan W; Abeynayake A; Binek A; Barbier-Torres L; Noureddin M; Nissen NN; Yildirim Z; Erbay E; Mato JM; Van Eyk JE; Lu SC
    Hepatology; 2022 Feb; 75(2):280-296. PubMed ID: 34449924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models.
    Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Santos-Laso A; Azkargorta M; Elortza F; Martinez-Chantar ML; Perugorria MJ; Aspichueta P; Marzioni M; LaRusso NF; Bujanda L; Drenth JPH; Banales JM
    J Hepatol; 2021 Feb; 74(2):394-406. PubMed ID: 32950589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin.
    Fang S; Qiu J; Wu Z; Bai T; Guo W
    Oncotarget; 2017 Jul; 8(30):49783-49795. PubMed ID: 28572537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
    Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
    Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.
    Tomasi ML; Ramani K; Ryoo M; Cossu C; Floris A; Murray BJ; Iglesias-Ara A; Spissu Y; Mavila N
    FASEB J; 2018 Jun; 32(6):3278-3288. PubMed ID: 29401608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-Conjugating Enzyme 9 Phosphorylation as a Novel Mechanism for Potentiation of the Inflammatory Response.
    Tomasi ML; Ramani K; Ryoo M
    Am J Pathol; 2016 Sep; 186(9):2326-36. PubMed ID: 27561301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
    He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
    Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
    Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
    Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization.
    Wang F; Sun F; Luo J; Yue T; Chen L; Zhou H; Zhang J; Yang C; Luo X; Zhou Q; Zhu H; Li J; Yang P; Xiong F; Yu Q; Zhang H; Zhang W; Xu A; Zhou Z; Lu Q; Eizirik DL; Zhang S; Wang CY
    Cell Death Dis; 2019 Nov; 10(12):892. PubMed ID: 31767832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
    Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
    Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
    López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
    Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-Adenosylmethionine and methylthioadenosine inhibit β-catenin signaling by multiple mechanisms in liver and colon cancer.
    Li TW; Peng H; Yang H; Kurniawidjaja S; Panthaki P; Zheng Y; Mato JM; Lu SC
    Mol Pharmacol; 2015 Jan; 87(1):77-86. PubMed ID: 25338671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity.
    Su YF; Yang T; Huang H; Liu LF; Hwang J
    PLoS One; 2012; 7(4):e34250. PubMed ID: 22509284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer.
    Lu SC; Mato JM
    Alcohol; 2005 Apr; 35(3):227-34. PubMed ID: 16054984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3 Activates SUMO-Conjugating
    Wang CM; Yang WH; Liu R; Wang L; Yang WH
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Ubc9 for cancer therapy.
    Mo YY; Moschos SJ
    Expert Opin Ther Targets; 2005 Dec; 9(6):1203-16. PubMed ID: 16300471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.